| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/24/2007 | CN1296380C Pharmaceutical compound |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296356C CCR-3 receptor antagonists VII |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296082C Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation |
| 01/24/2007 | CN1296080C Liver-clearing blood pressure-lowering capsule and its preparation method |
| 01/24/2007 | CN1296068C Preparing and quality controlling method of Chinese traditional medicine composition |
| 01/24/2007 | CN1296062C Preparation method of Codonopsis effective part and formulation of codenopsis extract |
| 01/24/2007 | CN1296053C Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/24/2007 | CN1295974C Eyesight-improving tea of Chinese wolfberry fruit and chrysanthemum |
| 01/23/2007 | US7166761 Detecting and monitoring adjustments in proteoglycan type receptor type protein tyrosine phosphatase (PTP) activity; enznyme inhibitors; diagnosing and treating gastrointestinal disorders |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166311 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 01/23/2007 | US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease |
| 01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/21/2007 | CA2553239A1 Method of treating steatorrhea in infants |
| 01/18/2007 | WO2007007993A1 Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea l. var. edulis extract |
| 01/18/2007 | WO2007007781A1 Novel use of processed product of blueberry leaf |
| 01/18/2007 | WO2007007159A2 Anti-madcam antibodies to treat uterine disorders |
| 01/18/2007 | WO2007007145A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006530A1 Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 01/18/2007 | WO2006121822B1 USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA |
| 01/18/2007 | WO2006100263A3 Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015765 5-(2-pyrazinyl)-4methyl-1,2-dithiol-3-thione (Oltipraz) and its metabolites; neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014766 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/18/2007 | CA2614796A1 Cynara scolymus extracts, the use thereof and formulations containing them |
| 01/18/2007 | CA2614698A1 Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 01/18/2007 | CA2613017A1 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | CA2599531A1 Metformin methods and formulations for treating chronic constipation |
| 01/17/2007 | EP1743944A1 Novel method of screening |
| 01/17/2007 | EP1743893A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742667A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same |
| 01/17/2007 | EP1742645A1 Compressed pharmaceutical compositions comprising peg and electrolytes |
| 01/17/2007 | EP1450762B1 Novel formulation |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1170013B1 Drugs, foods, drinks and feeds containing cocoa component |
| 01/17/2007 | CN1898385A Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 01/17/2007 | CN1898240A Imidazopyrazine tyrosine kinase inhibitors |
| 01/17/2007 | CN1896270A Therapeutic and preventing methods for bone loss |
| 01/17/2007 | CN1896216A Wine and its brewing method |
| 01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896091A Preparation of swine sulfodeoxy-cholalin |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895669A Mucosa-immune composite adjuvant |
| 01/17/2007 | CN1895668A Composite mucosa immunoadjuvant for oral vaccine |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1895658A Stomach-nourishing beverage |
| 01/17/2007 | CN1895640A Liver-nourishing electruary |
| 01/17/2007 | CN1895639A Chinese-medicinal powder for treating liver disease and its preparation |